{"name":"Vertero Therapeutics","slug":"vertero-therapeutics","ticker":"","exchange":"","domain":"vertero.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNWExGaTdZcGFkR2hhMXh2eGZHNWQwU3JtNE8wZUVkblhuZWdnVFlDUENxN3pyTlh6aWd4eW12d0swSGpKVHJaRDN2SENMak12YkdNNnQtTEFwRlZuYzVKTEEtMG14WndfQ1ZFV3VvVFpzN2tCU0FyUElHRTN6YWo0c0pUOVBreVhPR2UwRlVEZndoVnZhNGVWN1V5dHJCbHp2WGNZWUU1bkZsRXNITXN0ejZLcjJpaHZPeDRtRnJlNXRUWjJiY2oxcWNkOUpRUmNLTW9vTnRXZjFScFE4MWJUemxMRnkzS05INmpDUVcxeW9hVWpV?oc=5","date":"2025-12-16","type":"pipeline","source":"GlobeNewswire","summary":"Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer - GlobeNewswire","headline":"Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNb2QwTGhTSzlxSDFLdkdsTlZBMFZIT04yRzVXS2hJSFR2NWFXZ3NScmJsRjZ5dklHXzJmU2J6VEhrY3hUTHNjUlhDZWZjN1pkQVJlTEFrVHYtWmYxTjBDVHFoYXk4NVdSeUVOc0VFcDBuNUZLTExXT0MxaW5uS1FSZGk0TVBvMElZYlItdTRyZHNGMHRYSXRCVTlsTUROaFlGd3JZU2xn?oc=5","date":"2025-12-05","type":"trial","source":"endpoints.news","summary":"Ex-Intercept CEO to take over at Altimmune; Carolyn Bertozzi leaves Alnylam’s board - endpoints.news","headline":"Ex-Intercept CEO to take over at Altimmune; Carolyn Bertozzi leaves Alnylam’s board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQbFdqR01sV0V5bkp2RmFmNHpsclNSVVVvWDNtaXVoaEJ4WFNibkNnbXJ1ZFNndC1yRTFJcl9TZTNyX2YzMFZWaFVkejRyQkU5YzRwOTZwbFA2bllGdjd3Sl9Pb283M202czZkVEZmS0RCb2VBU0U0QVJ6ZmE1ZlpvRU9FS2swT2R1M1N5TWJBY0N2WjVoN0ptWkdRWE9PZzh5dmpFWmJxQVlEYzMzUEE?oc=5","date":"2025-11-16","type":"trial","source":"MedCity News","summary":"Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs - MedCity News","headline":"Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQNnNZalB6TDQzcEhlZWpRQXVhNkhpWV9MM0o4dmlfWjEzRVAtMUVrenZHVFdpblE3Wnl1MjlmN1pzTmFLQThOdllCZjJkR2J6M0xOZm5UYTIwSmJsVkdIUWdIbF9TZmVEQXZLVmEyVC1Id3VFVFdvSTVYdmh0UWlfbnBqdGRKY0hDRlVGOVlZN3RRdjdaX1lLOGptRFlsTnNXZUR3b3RlQnk?oc=5","date":"2025-10-21","type":"pipeline","source":"Fierce Pharma","summary":"Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises $20M - Fierce Pharma","headline":"Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises $20M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNdGlFcDJreW51aVpWUUdFbTN4aDVjZXV0NTc3NWdFMWZtZjlRcDEtbzlHWjAwZEFyTVdnV1pRSVUydDZTVEhfak44Rk1YcU9SdTd6cGxtcmNzMG9TRmpTbVFqWGNXQkhfaVJsbFl4aWx6WlRxMThUb0NFdzdHc2daYXhGNjl3b0dNZXY1TWNKVW1TQ3EtRUZDNUo0bkZGaHlwaHMxcU5QTVRUaWdub0hMN1BzV3paQzYyY1FWbWhrcTJqbEZBcmlCUlFQU00xMENLRmd3VkZvMktZSG9wNTNRdndhZUFUaXJxVEtDMEoxMmtFem94U3RRRHJOeUJIQ0k?oc=5","date":"2025-10-21","type":"pipeline","source":"GlobeNewswire","summary":"Vertero Unveils New Strategic Direction Focused on Breaking Barriers in Neurodegenerative Diseases - GlobeNewswire","headline":"Vertero Unveils New Strategic Direction Focused on Breaking Barriers in Neurodegenerative Diseases","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}